Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Wexler

Showing results (141-150 of 153) with videos related to

Pageof 16
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumorsE Izumchenko, K Paz, D Ciznadija, et al.
Nature Genetics|May 6, 2014
A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutationsShinji Kohsaka, Neerav Shukla, Nabahet Ameur, et al.
Nature Cancer|August 18, 2022
Single-cell analysis and functional characterization uncover the stem cell hierarchies and developmental origins of rhabdomyosarcomaYun Wei, Qian Qin, Chuan Yan, et al.
Cold Spring Harbor Perspectives in Medicine|November 5, 2014
Rhabdomyosarcoma: current challenges and their implications for developing therapiesSimone Hettmer, Zhizhong Li, Andrew N Billin, et al.
Molecular Cancer Research : MCR|March 23, 2021
Comprehensive Molecular Profiling of Desmoplastic Small Round Cell TumorEmily K Slotkin, Anita S Bowman, Max F Levine, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcomaMichael D Kinnaman, Simone Zaccaria, Alvin Makohon-Moore, et al.
Cancer Research|October 9, 2023
Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent OsteosarcomaMichael D Kinnaman, Simone Zaccaria, Alvin Makohon-Moore, et al.
JCO Oncology Advances|May 7, 2025
ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial ResultsEmily K Slotkin, Audrey Mauguen, Filemon S Dela Cruz, et al.
Pediatric Blood & Cancer|June 22, 2019
Insights into pediatric rhabdomyosarcoma research: Challenges and goalsMarielle E Yohe, Christine M Heske, Elizabeth Stewart, et al.
Cancers|March 28, 2026
Biological Advances and Current Challenges for Pediatric RhabdomyosarcomaKatie E Hebron, Patience Odeniyide, Yun Wei, et al.
Pageof 16

Showing results (141-150 of 153) with videos related to

Sort By:
Pageof 16
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumorsE Izumchenko, K Paz, D Ciznadija, et al.
Nature Genetics|May 6, 2014
A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutationsShinji Kohsaka, Neerav Shukla, Nabahet Ameur, et al.
Nature Cancer|August 18, 2022
Single-cell analysis and functional characterization uncover the stem cell hierarchies and developmental origins of rhabdomyosarcomaYun Wei, Qian Qin, Chuan Yan, et al.
Cold Spring Harbor Perspectives in Medicine|November 5, 2014
Rhabdomyosarcoma: current challenges and their implications for developing therapiesSimone Hettmer, Zhizhong Li, Andrew N Billin, et al.
Molecular Cancer Research : MCR|March 23, 2021
Comprehensive Molecular Profiling of Desmoplastic Small Round Cell TumorEmily K Slotkin, Anita S Bowman, Max F Levine, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcomaMichael D Kinnaman, Simone Zaccaria, Alvin Makohon-Moore, et al.
Cancer Research|October 9, 2023
Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent OsteosarcomaMichael D Kinnaman, Simone Zaccaria, Alvin Makohon-Moore, et al.
JCO Oncology Advances|May 7, 2025
ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial ResultsEmily K Slotkin, Audrey Mauguen, Filemon S Dela Cruz, et al.
Pediatric Blood & Cancer|June 22, 2019
Insights into pediatric rhabdomyosarcoma research: Challenges and goalsMarielle E Yohe, Christine M Heske, Elizabeth Stewart, et al.
Cancers|March 28, 2026
Biological Advances and Current Challenges for Pediatric RhabdomyosarcomaKatie E Hebron, Patience Odeniyide, Yun Wei, et al.
Pageof 16